Genomic abnormalities, other than those at the neurofibromin 1 (NF1) locus, have rarely been detected in benign neurofibromas but are numerous in MPNSTs suggesting that many secondary genetic changes are required for the transformation from a benign neurofibroma to MPNST. The gene discussed is NF1; the disease is neurofibroma.